• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)

This product is currently not available for purchase.

RELATED PRODUCTS

Pharmaceuticals in Canada Product Image

Pharmaceuticals in Canada

  • ID: 30824
  • January 2011
  • Region: Canada
  • 39 pages
  • Datamonitor

FEATURED COMPANIES

  • Apotex, Inc.
  • AstraZeneca Plc
  • Johnson & Johnson
  • Pfizer Inc
  • MORE

The Pharmaceuticals in Canada industry profile is an essential resource for top-level data and analysis covering the Pharmaceuticals industry. It includes data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

- Contains an executive summary and data on value, volume and/or segmentation

- Provides textual analysis of Pharmaceuticals in Canada’s recent performance and future prospects

- Incorporates in-depth five forces competitive environment analysis and scorecards

- Includes a five-year forecast of Pharmaceuticals in Canada

- The leading companies are profiled with supporting key financial metrics

- Supported by the key macroeconomic and demographic data affecting the market

Highlights

- Detailed information is included on market size, measured by value and/or volume

- Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

- Market shares are covered by manufacturer or brand

Why you should buy this report

- Spot future READ MORE >

FEATURED COMPANIES

  • Apotex, Inc.
  • AstraZeneca Plc
  • Johnson & Johnson
  • Pfizer Inc
  • MORE

EXECUTIVE SUMMARY
MARKET OVERVIEW
Market definition
Research highlights
Market analysis
MARKET VALUE
MARKET SEGMENTATION I
MARKET SEGMENTATION II
MARKET SHARE
FIVE FORCES ANALYSIS
Summary
Buyer power
Supplier power
New entrants
Substitutes
Rivalry
LEADING COMPANIES
Apotex, Inc.
AstraZeneca PLC
Johnson & Johnson
MARKET FORECASTS
Market value forecast
MACROECONOMIC INDICATORS
APPENDIX
Methodology
Industry associations
Related Datamonitor research
Disclaimer
ABOUT DATAMONITOR
Premium Reports
Summary Reports
Datamonitor consulting

LIST OF TABLES
Table 1: Canada pharmaceuticals market value: $ billion, 2006–10(e)
Table 2: Canada pharmaceuticals market segmentation I:% share, by value, 2010(e)
Table 3: Canada pharmaceuticals market segmentation II: % share, by value, 2010(e)
Table 4: Canada pharmaceuticals market share: % share, by value, 2010(e)
Table 5: Apotex, Inc.: key facts
Table 6: AstraZeneca PLC: key facts
Table 7: AstraZeneca PLC: key financials ($)
Table 8: AstraZeneca PLC: key financial ratios
Table 9: Johnson & Johnson: key facts
Table 10: Johnson & Johnson: key financials ($)
Table 11: Johnson & Johnson: key financial ratios
Table 12: Canada pharmaceuticals market value forecast: $ billion, 2010–15
Table 13: Canada size of population (million), 2006–10
Table 14: Canada GDP (constant 2000 prices, $ billion), 2006–10
Table 15: Canada GDP (current prices, $ billion), 2006–10
Table 16: Canada inflation, 2006–10
Table 17: Canada consumer price index (absolute), 2006–10
Table 18: Canada exchange rate, 2006–10

LIST OF FIGURES
Figure 1: Canada pharmaceuticals market value: $ billion, 2006–10(e)
Figure 2: Canada pharmaceuticals market segmentation I:% share, by value, 2010(e)
Figure 3: Canada pharmaceuticals market segmentation II: % share, by value, 2010(e)
Figure 4: Canada pharmaceuticals market share: % share, by value, 2010(e)
Figure 5: Forces driving competition in the pharmaceuticals market in Canada, 2010
Figure 6: Drivers of buyer power in the pharmaceuticals market in Canada, 2010
Figure 7: Drivers of supplier power in the pharmaceuticals market in Canada, 2010
Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2010
Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2010
Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2010
Figure 11: AstraZeneca PLC: revenues & profitability
Figure 12: AstraZeneca PLC: assets & liabilities
Figure 13: Johnson & Johnson: revenues & profitability
Figure 14: Johnson & Johnson: assets & liabilities
Figure 15: Canada pharmaceuticals market value forecast: $ billion, 2010–15



- Apotex, Inc.
- AstraZeneca Plc
- Johnson & Johnson
- Pfizer Inc

Note: Product cover images may vary from those shown

Our Clients

Our clients' logos